نتائج البحث - "Uwe M. Martens"

1

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Organoplatinum Compounds, Colorectal cancer, Original Article – Clinical Oncology, Leucovorin, Disease, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Disease dynamics, FOLFOXIRI, Metastatic colorectal cancer, Panitumumab, General Medicine, Middle Aged, Primary tumor, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, Fluorouracil, Colorectal Neoplasms, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Randomization, BRAF, Combination chemotherapy, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, business.industry, Wild type, medicine.disease, Early tumor shrinkage, 030104 developmental biology, Tumor progression, Mutation, Primary tumor site, ras Proteins, Camptothecin, business, Depth of response

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6834639b3ec002c9bc256673519e750Test
https://doi.org/10.1007/s00432-020-03257-zTest

2

FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)

المؤلفون: Uwe M. Martens, Swen Wessendorf, Heinemann, Petra Buechner-Steudel, J. Greeve, Axel Florschütz, Thomas J. Ettrich, Andrea Tannapfel, Anke Reinacher-Schick, Thomas Seufferlein, Michael Geissler, Swantje Held, Jens Atzpodien, Jens Ricke, Max Seidensticker, Jorge Riera-Knorrenschild, Stephan Kanzler, Dominik Paul Modest, Dominik Nörenberg

المصدر: Journal of Clinical Oncology. 37:3401-3411

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b2c87cf9f825e3641aa69916765fb581Test
https://doi.org/10.1200/jco.19.01340Test

3

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

المؤلفون: Matthias Egger, Stephan Probst, Jörg Trojan, Alexander Reichart, Dirk M Behringer, Salah-Eddin Al-Batran, Volker Rethwisch, Michael Pohl, Gerald Illerhaus, Jan Stoehlmacher, Jörg Weniger, Daniel Pink, Wael Hozaeel, Rolf Mahlberg, Georg Martin Haag, Severin Daum, Carmen Löhr, Wolff Schmiegel, Michael Heike, G. Schuch, Timo Gaiser, Flot Aio Investigators, Thorsten Oliver Goetze, Helga Bernhard, Sebastian Belle, Nils Homann, Johannes Meiler, Hans-Georg Kopp, Nicole Prasnikar, Christian Teschendorf, Andreas Block, Michael Schenk, Volker Heinemann, Markus Moehler, Stefan Kasper, Claudia Pauligk, Kim Barbara Luley, Ralf Hofheinz, Harald Schmalenberg, Michael Kneba, Frank Kullmann, Wolf O. Bechstein, Jörg T. Hartmann, Uwe M. Martens, Martin Schuler, U. Lindig, Fuat Oduncu, Peter C. Thuss-Patience, Thomas Kraus, Gunnar Folprecht, Frank Mayer, Michael Koenigsmann, Elke Jäger, Wolfgang Fischbach, Stefan Mönig, Ludwig Fischer von Weikersthal, Martina Güntner, Karsten Schulmann

المصدر: The Lancet. 393:1948-1957

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb9328f246b91519e1997e982c1bc7cTest
https://doi.org/10.1016/s0140-6736Test(18)32557-1

4

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trial

المساهمون: Stahl, Michael (Beitragende*r), Mahlmann, Stefan (Beitragende*r)

مصطلحات موضوعية: Male, FOLFIRINOX, Leucovorin, Medizin, Phases of clinical research, Deoxycytidine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Induction Chemotherapy, Middle Aged, Neoadjuvant Therapy, Oxaliplatin, Treatment Outcome, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Fluorouracil, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Paclitaxel, Population, Antineoplastic Agents, Adenocarcinoma, Irinotecan, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Pancreatectomy, Albumins, Internal medicine, medicine, Humans, education, Aged, Neoplasm Staging, Hepatology, business.industry, Induction chemotherapy, medicine.disease, Gemcitabine, Pancreatic Neoplasms, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148Test

5

Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study

المؤلفون: Depenbusch R, Monika Engelhardt, G Illerhaus, A Salar, Hartmut Link, M Zaiss, Uwe M. Martens, Andreas Lammerich, A Köhler, Anton Buchner, S. Mahlmann, Peter Bias

المصدر: Supportive Care in Cancer

مصطلحات موضوعية: medicine.medical_specialty, Neutropenia, Filgrastim, Neutrophils, Population, Febrile neutropenia, Polyethylene Glycols, Granulocyte colony, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Granulocyte Colony-Stimulating Factor, medicine, Humans, education, Adverse effect, Chemotherapy-induced neutropenia, Lipegfilgrastim, 030304 developmental biology, Aged, 0303 health sciences, education.field_of_study, Stimulating factor (G-CSF), business.industry, Incidence (epidemiology), Incidence, Lymphoma, Non-Hodgkin, medicine.disease, Pegfilgrastim, Oncology, 030220 oncology & carcinogenesis, Absolute neutrophil count, Female, Original Article, business, B cell non-Hodgkin lymphoma, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8657188cc8b2101ff28372bdb39918Test
http://hdl.handle.net/10230/52526Test

6

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

المصدر: Lancet (London, England). 395(10236)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd0e8a8f5cae4bc6aab1b99e6a7d3a0Test
https://pubmed.ncbi.nlm.nih.gov/32472086Test

7

Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT

المؤلفون: Sabine Mai, Peter Kienle, Thomas Hoehler, Timo Gaiser, Ralf Hofheinz, Frederik Wenz, Christoph Plöger, Michael Geissler, Stefan Post, Kirsten Merx, Sebastian Belle, Udo Hieber, Melanie Kripp, Uwe M. Martens

المصدر: International Journal of Radiation Oncology*Biology*Physics. 99:867-875

مصطلحات موضوعية: Adult, Diarrhea, Male, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Panitumumab, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Epidermal growth factor receptor, Infusions, Intravenous, Aged, Neoplasm Staging, Skin, Aged, 80 and over, Radiation, Cetuximab, biology, Rectal Neoplasms, business.industry, Antibodies, Monoclonal, Radiotherapy Dosage, Chemoradiotherapy, Middle Aged, medicine.disease, Primary tumor, Clinical trial, Radiation therapy, Genes, ras, 030220 oncology & carcinogenesis, biology.protein, Female, Radiotherapy, Intensity-Modulated, Neoplasm Grading, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efbbd86a66df42fd7c31e0b94a5c62d6Test
https://doi.org/10.1016/j.ijrobp.2017.06.2460Test

8

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

المصدر: Leukemia
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lymphoma, Population, Medizin, Procarbazine, Gastroenterology, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Immunologic Factors, education, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, education.field_of_study, Hematology, business.industry, Remission Induction, Primary central nervous system lymphoma, Lomustine, medicine.disease, Surgery, Tumor Burden, Methotrexate, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cytarabine, Quality of Life, Rituximab, Original Article, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b788727f36c75ddb2bbdc7cd8e48373Test
http://europepmc.org/articles/PMC5383936Test

9

EORTC-1203-GITCG - the 'INNOVATION'-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

المؤلفون: Murielle Mauer, Markus Moehler, Peter C. Thuss-Patience, Uwe M. Martens, Sun Young Rha, Heike I. Grabsch, Anna Dorothea Wagner, Florian Lordick, Carmela Caballero, Lothar Mueller, Annemieke Cats, Yoon-Koo Kang, Masanori Tokunaga, Sandrine Marreaud, Annelie Elme

المساهمون: Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology

المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer, 19:494. BioMed Central Ltd
BMC Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Esophageal Neoplasms, Receptor, ErbB-2, SURGERY, medicine.medical_treatment, Gastroenterology, Study Protocol, NEOADJUVANT CHEMOTHERAPY, Antineoplastic Agents, Immunological, 0302 clinical medicine, FOLFOX, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, OXALIPLATIN, Netherlands, Aged, 80 and over, DOCETAXEL, Middle Aged, OPEN-LABEL, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Chemotherapy regimen, Neoadjuvant Therapy, Progression-Free Survival, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Gastro-esophageal junction cancer, Esophagogastric Junction, Fluorouracil, Pertuzumab, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, CAPECITABINE, Adenocarcinoma, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Capecitabine, Young Adult, 03 medical and health sciences, Breast cancer, Stomach Neoplasms, Internal medicine, HER2, Republic of Korea, REGRESSION, Genetics, medicine, Humans, BREAST-CANCER, Perioperative Period, Aged, Cisplatin, Chemotherapy, Perioperative chemotherapy, business.industry, Trastuzumab, medicine.disease, Oxaliplatin, 030104 developmental biology, business, Gastric cancer, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98819406c91ecd11f368ecbad6cc7175Test
https://eprints.whiterose.ac.uk/151178/1/wrro_151178.pdfTest

10

Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Medizin, Dexamethasone, Bortezomib, Study Protocol, 610 Medical sciences Medicine, 0302 clinical medicine, Autologous stem-cell transplantation, Multiple myeloma, Clinical endpoint, Lenalidomide/administration & dosage, Prospective Studies, Elotuzumab, Lenalidomide, Melphalan, hematology, Hematopoietic Stem Cell Transplantation, Induction Chemotherapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, elotuzumab, Multiple Myeloma/therapy, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Female, autologous stem cell transplant, Antibodies, Monoclonal, Humanized/administration & dosage, medicine.drug, Dexamethasone/administration & dosage, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Maintenance Chemotherapy, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Humans, Aged, Chemotherapy, business.industry, medicine.disease, Survival Analysis, Consolidation Chemotherapy, 030104 developmental biology, Quality of Life, Bortezomib/administration & dosage, business, high-dose chemotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b58d1361d94b3c6f22e13502a6ffd2Test
http://europepmc.org/articles/PMC6537200Test

تنقيح النتائج